Revvity | PKI - Debt



Revvity reported $3.19B in Debt for its fiscal quarter ending in September of 2024.

Debt Change Date
Adcock Ingram Holdings ZAR 480.07M 155.03M Dec/2023
Agilent USD 3.39B 458M Oct/2024
Align Technology USD 0 129.09M Sep/2024
Bio Techne USD 300M 119.54M Sep/2024
Bio-Rad Laboratories USD 1.2B 191.35M Sep/2024
Bruker USD 2.3B 27.6M Sep/2024
Catalent USD 4.95B 29M Sep/2024
Celltrion KRW 2.2T 26.33B Sep/2024
Charles River Laboratories USD 2.33B 508.11M Sep/2024
Cspc Pharmaceutical CNY 388.87M 318.03M Jun/2024
Danaher USD 17.52B 514M Sep/2024
Dentsply International USD 2.22B 5M Sep/2024
Dianthus Therapeutics USD 0 407K Sep/2024
Ecofibre AUD 25.21M 1.83M Dec/2023
Edwards Lifesciences USD 693M 6.2M Jun/2024
Exact Sciences USD 2.58B 178.3M Sep/2024
Hologic USD 2.53B 24.6M Sep/2024
Illumina USD 1.99B 933M Sep/2024
Intuitive Surgical USD 0 0 Sep/2024
IQVIA Holdings USD 13.51B 62M Sep/2024
Kangmei Pharma CNY 215.93M 40.04M Sep/2024
Knight Therapeutics CAD 58.22M 109K Sep/2024
Laboratorios Farma EUR 121.16M 39.38M Jun/2024
Laboratory Of America USD 6.83B 858.4M Sep/2024
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 2.43M 134K Dec/2023
Mettler Toledo International USD 2.08B 19.6M Sep/2024
Myriad Genetics USD 39M 104.3M Sep/2024
Neuren Pharmaceuticals AUD 0 0 Dec/2021
Organigram Holdings CAD 100K 18K Jun/2024
Patterson Companies USD 898.93M 135.99M Jul/2024
Pharma Mar EUR 53.07M 13.68M Sep/2024
Qiagen NV USD 1.92B 518.22M Sep/2024
Quest Diagnostics USD 6.97B 1.88B Sep/2024
Quidel USD 2.55B 220.4M Sep/2024
Repligen USD 521.61M 221.25M Sep/2024
Revvity USD 3.19B 810.4M Sep/2024
Sartorius EUR 4.53B 98.7M Sep/2024
Sino Biopharmaceutical CNY 9.68B 2.9B Jun/2024
Thermo Fisher Scientific USD 35.31B 92M Sep/2024
Tilray USD 388.42M 1.1M Aug/2024
Waters USD 1.9B 183.89M Sep/2024
Zz Pientze Pharmaceu 1.18B 28.21M Sep/2024